Viewing Study NCT02915432

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:56 PM
Ignite Modification Date: 2026-02-23 @ 11:34 AM
Study NCT ID: NCT02915432
Status: UNKNOWN
Last Update Posted: 2021-12-13
First Post: 2016-09-21
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: The Study to Evaluate Toripalimab (JS001) in Patients With Advanced GC, ESCC, NPC, HNSCC
Sponsor: Shanghai Junshi Bioscience Co., Ltd.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Gastric Adenocarcinoma View
None Esophageal Squamous Cell Carcinoma View
None Nasopharyngeal Carcinoma View
None Head and Neck Squamous Cell Carcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Anti PD-1 View
None JS001 View
None Gastric Adenocarcinoma View
None Esophageal Squamous Cell Carcinoma View
None Nasopharyngeal Carcinoma View
None Head and Neck Squamous Cell Carcinoma View
None Simon's Two Stage View
None ORR View